These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 20035611)

  • 41. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Roberts JA; Lipman J
    Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
    Akers KS; Niece KL; Chung KK; Cannon JW; Cota JM; Murray CK
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S163-70. PubMed ID: 24770557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic dosing in critical illness.
    McKenzie C
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 2():ii25-31. PubMed ID: 21398304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions.
    Lipš M; Siller M; Strojil J; Urbánek K; Balík M; Suchánková H
    Int J Antimicrob Agents; 2014 Oct; 44(4):358-62. PubMed ID: 25216543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
    Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
    Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
    [No Abstract]   [Full Text] [Related]  

  • 49. Extended-interval aminoglycoside dosing in pediatrics.
    Jenh AM; Tamma PD; Milstone AM
    Pediatr Infect Dis J; 2011 Apr; 30(4):338-9. PubMed ID: 21407038
    [No Abstract]   [Full Text] [Related]  

  • 50. Towards better ICU antibiotic dosing.
    Lipman J
    Crit Care Resusc; 2000 Dec; 2(4):282-9. PubMed ID: 16597315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
    Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
    Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?
    O'Shea S; Duffull S; Johnson DW
    Semin Dial; 2009; 22(3):225-30. PubMed ID: 19386073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.
    De Waele JJ; De Neve N
    Minerva Anestesiol; 2014 Oct; 80(10):1135-42. PubMed ID: 24326971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.
    McCormack JP; Schentag JJ
    Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.
    Mann HJ; Fuhs DW; Awang R; Ndemo FA; Cerra FB
    Clin Pharm; 1987 Feb; 6(2):148-53. PubMed ID: 3665367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
    Awissi DK; Beauchamp A; Hébert E; Lavigne V; Munoz DL; Lebrun G; Savoie M; Fagnan M; Amyot J; Tétreault N; Robitaille R; Varin F; Lavallée C; Pichette V; Leblanc M
    Pharmacotherapy; 2015 Jun; 35(6):600-7. PubMed ID: 26095008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.